JLP Health: Press Releases

Media

Press Release: Achilles heel of glioblastoma. JLP Health and its partners discover combinatorial treatment option for incurable brain tumors

By studying the mechanism of action from a widely used Nobel Prize winning anti-malaria drug named Artemisinin, the authors were able to pharmacologically sensitize brain cancer cells to this natural substance and selectively eliminate brain tumors in numerous relevant model systems. Vienna,…

Press Release: Emerging Crimean-Congo Haemorrhagic Fever Virus: JLP Health Discovery Enables Novel Treatment Options

With the help of JLP Health’s screening technology, scientists discovered that impairing LDLR decreased disease symptoms in mice infected with CCHF virus. Vienna, Austria, 28th of March 2024 – A study published today in Nature Microbiology, carried out by scientists from JLP Health GmbH in…

Neue Wege zum Erfolg in der Krebs- und Virenforschung

Zwei bedeutende und international agierende Stiftungen aus dem Innviertel sind die neuen strategischen Partner der JLP Health GmbH. - JLP Health Press Release 4.5. 2021 (German)

JLP Health forscht gemeinsam mit renommierten Partnern an neuen Ansätzen zur Bekämpfung von COVID-19 und anderen tödlichen Viren.

Das Wiener Unternehmen JLP Health GmbH ist Teil eines hochkarätig besetzten Konsortiums, um neue antivirale Medikamente gegen SARS-CoV-2 herzustellen - JLP Health Press Release 7.10. 2020 (German)